2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics 2008 Barcelona - European Society of Human Genetics

24.08.2013 Views

Molecular and biochemical basis of disease School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Islamic Republic of Iran, 4 Department of Clinical Chemistry, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Islamic Republic of Iran. Familial hypercholesterolemia (FH) is an autosomal dominant disorder caused mainly by mutations in the low-density lipoprotein receptor (LDLR) and apolipoprotein B (APOB) . Until now, the molecular basis of FH has been demonstrated in detail in many populations, but there is still very limited Molecular data concerning FH in Iran . The aim of this study was to characterize the LDLR and APOB gene mutations in an Iranian population . A total of 50 non-related Iranian heterozygous FH subjects were studied . All samples were initially tested for 3 common APOB gene mutations including R3500Q , R3500W and R3531C using PCR- RFLP assay . Subsequently, LDLR gene were screened partially (exons 2, 4, 6, 7, 8, 9, 10, 12 and 14) by PCR-SSCP analysis and positive results were confirmed by DNA sequencing. Four previously reported polymorphisms 1413 G >A, 1725 C >T, 1773 T > C and 2140 + 5G>A were found in 18% of population studied . Moreover, no variation was found in APOB gene . Our data indicated that LDLR and APOB gene mutations have not contribution to FH in Iranian population studied here . However, we examined 3 common APOB mutations and 9 exons of LDLR in only 50 patients, and to determine the role of these genes in developing FH in Iran, more samples/populations needed to be investigated for the whole coding regions and promoter of the genes . P05.049 correlation of mEFV gene mutations and bone mineral density in children with familial meditterian fever A. Bukulmez 1 , H. Samli 2 , U. Dundar 3 , R. Koken 1 , V. Kavuncu 3 , M. Solak 4 ; 1 Afyon Kocatepe University, School of Medicine, Department of Pediatrics, Afyonkarahisar, Turkey, 2 Afyon Kocatepe University, School of Medicine, Department of Medical Genetics, Afyonkarahisar, Turkey, 3 Afyon Kocatepe University, School of Medicine, Department of Physical Medicine and Rehabilitation, Afyonkarahisar, Turkey, 4 Afyon Kocatepe University, School of Medicine, Department of Medical Biology, Afyonkarahisar, Turkey. Objective: Familial Mediterranean Fever (FMF) is an inherited disorder caused by an abnormal recessive gene Virtually all cases are due to a mutation in the MEFV gene, which codes for a protein called pyrin or marenostenin . The aim of this study is evaluating the correlation between bone mineral density and mutations in children with FMF . Methods: 36 prepupertal children diagnosed FMF according to Tel Hashomer Criteria were included in the study . Bone mineral density (BMD) was measured in all patients by dual energy X-ray absorptiometry, both at the lumbar spine (antero-posterior projection of L1-L4) and total body . BMD data were expressed as grams per centimeter square and standard deviation scores (Z score). The five MEFV gene mutations (M694V, M694I, V726A, M680I, E148Q) were scanned in all cases by PCR- ELISA method . According to the results of the genetic investigation, cases were grouped as cases with no scanned mutations and cases with heterozygous and homozygous mutations . Results: Both lumber vertebrae and total body bone mineral density of the patients were found to be low . No differences were detected among BMD values of the groups . Conclusion: In conclusion, no significant relation was detected between MEFV gene mutations and BMD in the patients with FMF . This result does not mean there is no low bone density risk in patients with FMF . Due to this, we think that study will be significant with more patients and in association with biochemical markers, signs of bone health . P05.050 the prevalence of familial mediterranean fever gene mutations in patients with rheumatic heart disease Y. Tunca, I. Simsek, C. Koz, I. Sari, H. Erdem, S. Pay, D. Gul, A. Dinc; GATA, Ankara, Turkey. BACKGROUND: Acute rheumatic fever (ARF) has been considered in the differential diagnosis of familial Mediterranean fever (FMF) because these two diseases have some clinical and laboratory similarities . There are also autopsy reports of rheumatic mitral stenosis in patients with FMF and amyloidosis . Moreover, a history of ARF during childhood is not infrequent in patients with FMF . OBJECTIVE: To investigate the prevalence of familial Mediterranean fever gene mutations in patients with rheumatic heart disease . METHODS: A total of 21 patients with rheumatic heart disease were enrolled . The diagnosis of mitral stenosis was established with echocardiography or angiography . Patients with predominant mitral regurgitation or isolated aortic or tricuspid valve disease were excluded . Genetic analysis was carried out by the NanoChip® Molecular Genetics Workstation . RESULTS: Four of the patients were found to have heterozygote MEFV mutations . Three of these mutations were E148Q/- and one was V726A/- . CONCLUSION: In the light of our preliminary results, we may conclude that the frequency of MEFV mutations are not higher than the normal population . Further studies with larger sample sizes are needed for better understanding the possible relationship between these two disorders and to clarify whether specific mutations play role in the pathogenesis . P05.051 comparison of mutations screening assay on mEFV gene in turkish FmF patients. B. Eroglu Kesim 1,2 , O. Kagnıcı 1,3 , G. Karatas 1 , S. Guz Eroglu 1 , S. Eraslan 1,4 , A. Dagdemir 1 , Y. Laleli 1 ; 1 Duzen Laboratuaries Groups, İstanbul, Turkey, 2 Sisli Etfal Training and Research Hospital,Medical Genetic ., Istanbul, Turkey, 3 Istanbul university institute for experimental medicine, Istanbul, Turkey, 4 Genklinik Genetics , Genetıc Diagnostic Center, Istanbul, Turkey. Familial Mediterranean fever (FMF) is an autosomal-recessive disorder characterized by recurrent attacks of fever and serositis common in eastern Mediterranean populations . Over 70 mutations have been identified in the MEFV gene responsible for FMF. The aim of this study is to determine the frequency of the mutations which has been reported comparatively rare, to define the most effective mutation set, and to select the most suitable DNA analysis system for Turkish FMF patients . 1709 patients were referred by specialists to the Moleculer Genetic Diagnostic Centrum of Duzen Laboratuaries Groups from various regions of Turkey . First, mutation screening of the MEFV gene was performed for the 3 most common mutations, namely M694V, M680I, V726A, in 1182 unrelated patients by polymerase chain reaction and restriction enzyme digestion analysis . The rate of mutation detection was 46 .2% and these three mutations accounted for 64 .4%, 22 .6% and 12 .7% of the alleles, respectively . . Second, we investigated 12 mutations (E148Q, P369S, F479L, M680I G>C, M680 G>A, 1692del, M694V, M694I, K695R, V726A, A744S and R761H) in 527 patients using reverse dot-blot hybridization (RDBH) assay . We found the rate of detection to be 50 .5% . The most common mutations were found to be M694V, E148Q, M680I, V726A and R761H . Percengate of these mutations were 47 .7, 19 .9, 14 .3, 9 .8 and 4 .1, respectively . Our study showed that the RDBH method increased the detection rate of FMF mutations about 4% compared to PCR-RFLP method for Turkish population . P05.052 missense mutations in the forkhead domain of FOXL lead to subcellular mislocalization, protein aggregation and impaired transactivation. E. De Baere 1 , L. Moumné 2 , H. Peters 3 , B. P. Leroy 4 , A. De Paepe 1 , R. A. Veitia 2 , D. Beysen 1 ; 1 Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium, 2 IN- SERM U567, Team21, Genetics and Development Department, Institut Cochin, Paris, France, 3 Institute of Medical Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany, 4 Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium. Mutations of FOXL2, encoding a forkhead transcription factor, have been shown to cause blepharophimosis syndrome (BPES), characterized by an eyelid malformation variably associated with premature ovarian failure . Recently, polyalanine expansions and truncating mutations were shown to lead to protein mislocalization, aggregation and altered transactivation . Here, we study the molecular consequences of 17 naturally occurring FOXL2 missense mutations on subcellular localization and transactivation capacities in cellular systems . Most of these mutations map to the conserved DNA-binding forkhead domain (FHD) . According to their subcellular localization in COS-7 cells, the mutant proteins could be divided into four groups . We also studied the trans-

Molecular and biochemical basis of disease activation capacity of the mutants in FOXL2 expressing granulosa-like cells (KGN) . Several mutants led to a loss-of-function, while others might induce a dominant negative effect . Interestingly, one mutant that is located outside the FHD (S217F), proved to be hypermorphic and to have no effect on intracellular protein distribution . Clinically this mutation gives rise to a mild BPES phenotype, and to growth hormone deficiency. In general, missense mutations located in the FHD lead to a classical BPES phenotype, but cannot be correlated with the presence of an ovarian phenotype . However, a potential predictive value of localization and transactivation assays in the making of genotypephenotype correlations is proposed. In conclusion, this is the first study to demonstrate that a significant number of missense mutations in the FHD of FOXL2 lead to mislocalization, protein aggregation and altered transactivation, and to provide insights into the pathogenesis associated with missense mutations of FOXL2 in human disease . P05.053 the spectrum of GALt gene mutations in south regions of Russia S. Mordanov, F. Lagkueva, S. Matulevich, S. Amelina, G. Listopad, S. Kutsev; Rostov State Medical University, Rostov-on-Don, Russian Federation. Galactose-1-phosphate uridyltransferase (GALT) deficiency galactosemia is clinically heterogeneous autosomal recessive disorder . Newborn screening can identify patients with GALT deficiency galactosaemia. The diagnosis needs to be confirmed by enzyme activity test. Unfortunately, in many cases the results of GALT activity measurement can be ambiguous and further molecular testing is required . More than 200 point mutations were revealed in the GALT gene, but the prevalence of these mutations varies among ethnic groups . Classical galactosemia newborn screening was started in Russia during 2006/2007 years . Total of 160 990 newborns were screened in South Russia and 11 patients with galactose level more than 7,2 mg/dL were revealed . Blood samples of this patients were submitted for confirmatory testing for classical galactosaemia . The GALT gene were sequenced in all cases. The mutational spectrum included five missense mutations M142L, H186Y, Q188R, K285 N, N314D . The classical galactosemia was revealed in 4 cases with genotypes Q188R / Q188R, K285 N / M142L, H186Y / N, K285N / N; Duarte variant was revealed in 5 cases with genotypes Q188R / N314D, Q188R / N314D, , N314D / N314D, N314D / N, N314D / N . In 2 cases mutations were not founded P05.054 Novel mutations in the gap junction gene GJB2 show that keratoderma is associated with connexin protein transport defects M. A. M. Van Steensel1 , E. A. de Zwart-Storm1 , P. Martin2 , M. van Geel1 ; 1 2 University of Maastricht, Maastricht, The Netherlands, University of Glasgow, Glasgow, United Kingdom. Mutations in the skin expressed gap junction gene GJB2 (coding for connexin26) cause a plethora of sometimes severe skin disorders with sensory deafness. Specific mutations are associated with distinct phenotypes and the reasons for this strong genotype-phenotype correlation are poorly understood . Commonly used functional parameters of gap junction functionality, such as dye transfer and electrical conductance, do not correlate with disease phenotype or severity . We have now identified a number of novel mutations that are specifically associated with palmoplantar keratoderma. Using fluorescent fusion proteins, we show that this skin symptom may be specifically caused by protein transport defects . What’s more, its severity is inversely correlated to that of the transport defect . We are now working to understand the cellular sequelae of the disturbed protein trafficking. Preliminary data indicate that ER stress responses may be involved . P05.055 Analysis of GJB2 gene exon 2 in Latvian patients with nonsyndromic sensorineural hearing loss O. Sterna 1,2 , N. Pronina 1 , I. Grinfelde 1 , S. Kuske 3 , D. Bauze 1 , R. Lugovska 1 ; 1 Medical Genetics clinic, University Children’s Hospital, Riga, Latvia, 2 Rigas Stradins University, Riga, Latvia, 3 Latvian Childrens` Hearing centre, Riga, Latvia. Background: Nonsyndromic hearing impairment (NSHI) is the most common form of deafness . Mutations in the GJB2 gene, which encodes gap-junction beta-2 protein (connexin 26), are the main cause of recessive NSHI. It has been identified that one particular GJB2 mutation named 35delG is the most prevalent for the populations of the European origin . Materials: We obtained DNA samples from patients with prelingual NSHI in whom syndromic forms and environmental causes of deafness had been excluded, their relatives and individuals with hearing loss positive family history . Methods: DNA was extracted from whole blood . The GJB2 gene exon 2 analysis was performed using PCR, enzymatic restriction and automated sequencing . Results: 55 unrelated patients were screened for the GJB2 mutations . Mutations were detected in 67 of 110 (61%) tested alleles . Four different mutations in the GJB2 gene have been identified in Latvian patients with NSHI: 35delG, 311-324del14, 235delC and M34T . 28 patients (51%) are homozygous for 35delG mutation, four patients (7%) are compound heterozygotes for 35delG and 311-324del14 mutations, one patient (2%) has genotype 35delG/235delC and one patient (2%) is heterozygous for M34T mutation . One heterozygous 51del12insA mutation was detected in unaffected individual with positive family history . Conclusion: Our results verify the GJB2 mutations to be causative for NSHL and confirm previous reports on the mutation distribution. Still, the cause of hearing loss remains unclear for patients with no or single GJB2 mutation . However, GJB2 related diagnosis cannot be excluded until mutations in non-coding regions and adjacent GJB6 gene have been screened . P05.056 Role of CYP B mutations in Primary Open-Angle Glaucoma P. López-Garrido1,2 , F. Sánchez-Sánchez1,2 , J. Escribano1,2 ; 1Genetics, Castilla-La Mancha University Medical School, Albacete, Spain, 2Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain. Glaucoma is a complex and genetically heterogeneous disease characterized by the progressive apoptotic death of retinal ganglion cells . Primary open-angle glaucoma (POAG) is the most common form of glaucoma, featured by an adult onset (>40 years), a gonioscopically open angle, and a reduced outflow facility. Heterozygous mutations in CYP1B1 gene are presented in the 4-9% POAG patients of different populations . Our purpose is to establish the genotype-phenotype relationship in Spanish POAG patients carrying CYP1B1 mutations . We have analyzed the enzymatic activity of different CYP1B1 mutations found in these patients, in transfected HEK-293T cells . The CYP1B1 enzymatic activity assay was carried out using ethoxyresorufin as a substrate in a fluorimetric assay. CYP1B1 mutations found in POAG patients show reduced enzymatic activity, supporting that loss of function mutations may play a role in the development of POAG . P05.057 Analysis of secretion and processing of wild type myocilin and myocilin-glaucoma mutants co-expressed in cell lines J. Aroca-Aguilar 1,2 , F. Sánchez-Sánchez 1,2 , F. Martínez-Redondo 1,2 , M. Coca- Prados 3 , J. Escribano 1,2 ; 1 Área de Genética. Facultad de Medicina /CRIB. UCLM, Albacete, Spain, 2 Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality, Instituto de Salud Carlos III, Madrid, Spain, 3 Department of Ophthalmology and Visual Science, Yale University School of Medicine, 300 George St, R.8100, New Haven, 06510, CT, United States. Glaucoma is a leading cause of irreversible blindness worldwide . The main known risk factor for this disease is an elevated intraocular pressure (IOP), mainly caused by an increased resistance to aqueous humour outflow. Heterozygous mutations in the olfactomedin-like domain of the myocilin gene (MYOC) cause autosomal dominant juvenile-onset glaucoma, and approximately 4% of all adult-onset primary openangle glaucoma (POAG) cases . The mechanisms by which these mutations elevate IOP and cause glaucoma are currently controversial . It has been described that myocilin undergoes an intracellular endoproteolytic processing by calpain II, in the middle of the polypeptide chain, which is reduced by glaucoma-associated MYOC mutations . To gain insight into the molecular mechanisms by which mutations in the MYOC gene lead to glaucoma, we have analyzed, by SDS-PAGE 0

Molecular and biochemical basis <strong>of</strong> disease<br />

School <strong>of</strong> Medicine, Shahrekord University <strong>of</strong> Medical Sciences, Shahrekord,<br />

Islamic Republic <strong>of</strong> Iran, 4 Department <strong>of</strong> Clinical Chemistry, School <strong>of</strong> Medicine,<br />

Tabriz University <strong>of</strong> Medical Sciences, Tabriz, Islamic Republic <strong>of</strong> Iran.<br />

Familial hypercholesterolemia (FH) is an autosomal dominant disorder<br />

caused mainly by mutations in the low-density lipoprotein receptor<br />

(LDLR) and apolipoprotein B (APOB) . Until now, the molecular basis <strong>of</strong><br />

FH has been demonstrated in detail in many populations, but there is<br />

still very limited Molecular data concerning FH in Iran . The aim <strong>of</strong> this<br />

study was to characterize the LDLR and APOB gene mutations in an<br />

Iranian population .<br />

A total <strong>of</strong> 50 non-related Iranian heterozygous FH subjects were studied<br />

. All samples were initially tested for 3 common APOB gene mutations<br />

including R3500Q , R3500W and R3531C using PCR- RFLP<br />

assay . Subsequently, LDLR gene were screened partially (exons 2, 4,<br />

6, 7, 8, 9, 10, 12 and 14) by PCR-SSCP analysis and positive results<br />

were confirmed by DNA sequencing.<br />

Four previously reported polymorphisms 1413 G >A, 1725 C >T, 1773<br />

T > C and 2140 + 5G>A were found in 18% <strong>of</strong> population studied .<br />

Moreover, no variation was found in APOB gene . Our data indicated<br />

that LDLR and APOB gene mutations have not contribution to FH<br />

in Iranian population studied here . However, we examined 3 common<br />

APOB mutations and 9 exons <strong>of</strong> LDLR in only 50 patients, and<br />

to determine the role <strong>of</strong> these genes in developing FH in Iran, more<br />

samples/populations needed to be investigated for the whole coding<br />

regions and promoter <strong>of</strong> the genes .<br />

P05.049<br />

correlation <strong>of</strong> mEFV gene mutations and bone mineral density in<br />

children with familial meditterian fever<br />

A. Bukulmez 1 , H. Samli 2 , U. Dundar 3 , R. Koken 1 , V. Kavuncu 3 , M. Solak 4 ;<br />

1 Afyon Kocatepe University, School <strong>of</strong> Medicine, Department <strong>of</strong> Pediatrics,<br />

Afyonkarahisar, Turkey, 2 Afyon Kocatepe University, School <strong>of</strong> Medicine,<br />

Department <strong>of</strong> Medical <strong>Genetics</strong>, Afyonkarahisar, Turkey, 3 Afyon Kocatepe<br />

University, School <strong>of</strong> Medicine, Department <strong>of</strong> Physical Medicine and Rehabilitation,<br />

Afyonkarahisar, Turkey, 4 Afyon Kocatepe University, School <strong>of</strong> Medicine,<br />

Department <strong>of</strong> Medical Biology, Afyonkarahisar, Turkey.<br />

Objective: Familial Mediterranean Fever (FMF) is an inherited disorder<br />

caused by an abnormal recessive gene Virtually all cases are due to<br />

a mutation in the MEFV gene, which codes for a protein called pyrin<br />

or marenostenin . The aim <strong>of</strong> this study is evaluating the correlation<br />

between bone mineral density and mutations in children with FMF .<br />

Methods: 36 prepupertal children diagnosed FMF according to Tel<br />

Hashomer Criteria were included in the study . Bone mineral density<br />

(BMD) was measured in all patients by dual energy X-ray absorptiometry,<br />

both at the lumbar spine (antero-posterior projection <strong>of</strong> L1-L4)<br />

and total body . BMD data were expressed as grams per centimeter<br />

square and standard deviation scores (Z score). The five MEFV gene<br />

mutations (M694V, M694I, V726A, M680I, E148Q) were scanned in all<br />

cases by PCR- ELISA method . According to the results <strong>of</strong> the genetic<br />

investigation, cases were grouped as cases with no scanned mutations<br />

and cases with heterozygous and homozygous mutations .<br />

Results: Both lumber vertebrae and total body bone mineral density<br />

<strong>of</strong> the patients were found to be low . No differences were detected<br />

among BMD values <strong>of</strong> the groups .<br />

Conclusion: In conclusion, no significant relation was detected between<br />

MEFV gene mutations and BMD in the patients with FMF . This result<br />

does not mean there is no low bone density risk in patients with FMF .<br />

Due to this, we think that study will be significant with more patients<br />

and in association with biochemical markers, signs <strong>of</strong> bone health .<br />

P05.050<br />

the prevalence <strong>of</strong> familial mediterranean fever gene mutations<br />

in patients with rheumatic heart disease<br />

Y. Tunca, I. Simsek, C. Koz, I. Sari, H. Erdem, S. Pay, D. Gul, A. Dinc;<br />

GATA, Ankara, Turkey.<br />

BACKGROUND: Acute rheumatic fever (ARF) has been considered<br />

in the differential diagnosis <strong>of</strong> familial Mediterranean fever (FMF) because<br />

these two diseases have some clinical and laboratory similarities<br />

. There are also autopsy reports <strong>of</strong> rheumatic mitral stenosis in<br />

patients with FMF and amyloidosis . Moreover, a history <strong>of</strong> ARF during<br />

childhood is not infrequent in patients with FMF .<br />

OBJECTIVE: To investigate the prevalence <strong>of</strong> familial Mediterranean<br />

fever gene mutations in patients with rheumatic heart disease .<br />

METHODS: A total <strong>of</strong> 21 patients with rheumatic heart disease were<br />

enrolled . The diagnosis <strong>of</strong> mitral stenosis was established with echocardiography<br />

or angiography . Patients with predominant mitral regurgitation<br />

or isolated aortic or tricuspid valve disease were excluded .<br />

Genetic analysis was carried out by the NanoChip® Molecular <strong>Genetics</strong><br />

Workstation .<br />

RESULTS: Four <strong>of</strong> the patients were found to have heterozygote<br />

MEFV mutations . Three <strong>of</strong> these mutations were E148Q/- and one<br />

was V726A/- .<br />

CONCLUSION: In the light <strong>of</strong> our preliminary results, we may conclude<br />

that the frequency <strong>of</strong> MEFV mutations are not higher than the normal<br />

population . Further studies with larger sample sizes are needed for<br />

better understanding the possible relationship between these two disorders<br />

and to clarify whether specific mutations play role in the pathogenesis<br />

.<br />

P05.051<br />

comparison <strong>of</strong> mutations screening assay on mEFV gene in<br />

turkish FmF patients.<br />

B. Eroglu Kesim 1,2 , O. Kagnıcı 1,3 , G. Karatas 1 , S. Guz Eroglu 1 , S. Eraslan 1,4 , A.<br />

Dagdemir 1 , Y. Laleli 1 ;<br />

1 Duzen Laboratuaries Groups, İstanbul, Turkey, 2 Sisli Etfal Training and Research<br />

Hospital,Medical Genetic ., Istanbul, Turkey, 3 Istanbul university institute<br />

for experimental medicine, Istanbul, Turkey, 4 Genklinik <strong>Genetics</strong> , Genetıc Diagnostic<br />

Center, Istanbul, Turkey.<br />

Familial Mediterranean fever (FMF) is an autosomal-recessive disorder<br />

characterized by recurrent attacks <strong>of</strong> fever and serositis common<br />

in eastern Mediterranean populations . Over 70 mutations have been<br />

identified in the MEFV gene responsible for FMF. The aim <strong>of</strong> this study<br />

is to determine the frequency <strong>of</strong> the mutations which has been reported<br />

comparatively rare, to define the most effective mutation set,<br />

and to select the most suitable DNA analysis system for Turkish FMF<br />

patients .<br />

1709 patients were referred by specialists to the Moleculer Genetic<br />

Diagnostic Centrum <strong>of</strong> Duzen Laboratuaries Groups from various<br />

regions <strong>of</strong> Turkey . First, mutation screening <strong>of</strong> the MEFV gene was<br />

performed for the 3 most common mutations, namely M694V, M680I,<br />

V726A, in 1182 unrelated patients by polymerase chain reaction and<br />

restriction enzyme digestion analysis . The rate <strong>of</strong> mutation detection<br />

was 46 .2% and these three mutations accounted for 64 .4%, 22 .6%<br />

and 12 .7% <strong>of</strong> the alleles, respectively . . Second, we investigated 12<br />

mutations (E148Q, P369S, F479L, M680I G>C, M680 G>A, 1692del,<br />

M694V, M694I, K695R, V726A, A744S and R761H) in 527 patients<br />

using reverse dot-blot hybridization (RDBH) assay . We found the rate<br />

<strong>of</strong> detection to be 50 .5% . The most common mutations were found to<br />

be M694V, E148Q, M680I, V726A and R761H . Percengate <strong>of</strong> these<br />

mutations were 47 .7, 19 .9, 14 .3, 9 .8 and 4 .1, respectively . Our study<br />

showed that the RDBH method increased the detection rate <strong>of</strong> FMF<br />

mutations about 4% compared to PCR-RFLP method for Turkish population<br />

.<br />

P05.052<br />

missense mutations in the forkhead domain <strong>of</strong> FOXL lead to<br />

subcellular mislocalization, protein aggregation and impaired<br />

transactivation.<br />

E. De Baere 1 , L. Moumné 2 , H. Peters 3 , B. P. Leroy 4 , A. De Paepe 1 , R. A. Veitia 2 ,<br />

D. Beysen 1 ;<br />

1 Center for Medical <strong>Genetics</strong>, Ghent University Hospital, Ghent, Belgium, 2 IN-<br />

SERM U567, Team21, <strong>Genetics</strong> and Development Department, Institut Cochin,<br />

Paris, France, 3 Institute <strong>of</strong> Medical <strong>Genetics</strong>, Charité - Universitätsmedizin<br />

Berlin, Berlin, Germany, 4 Department <strong>of</strong> Ophthalmology, Ghent University Hospital,<br />

Ghent, Belgium.<br />

Mutations <strong>of</strong> FOXL2, encoding a forkhead transcription factor, have<br />

been shown to cause blepharophimosis syndrome (BPES), characterized<br />

by an eyelid malformation variably associated with premature<br />

ovarian failure . Recently, polyalanine expansions and truncating mutations<br />

were shown to lead to protein mislocalization, aggregation and<br />

altered transactivation . Here, we study the molecular consequences <strong>of</strong><br />

17 naturally occurring FOXL2 missense mutations on subcellular localization<br />

and transactivation capacities in cellular systems . Most <strong>of</strong> these<br />

mutations map to the conserved DNA-binding forkhead domain (FHD) .<br />

According to their subcellular localization in COS-7 cells, the mutant<br />

proteins could be divided into four groups . We also studied the trans-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!